Satomi Omotehara

Ms. Satomi Omotehara

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2015 in Journal of Medical Ultrasonics
Verified
Journal Article
Closed access
PDF file
SOSatomi Omotehara
Satomi Omotehara
MNMutsumi Nishida
Mutsumi Nishida
MSMegumi Satoh
Megumi Satoh
MIMamiko Inoue
Mamiko Inoue
YKYusuke Kudoh
Yusuke Kudoh
CSChikara Shimizu
Chikara Shimizu

31 January 2023 in Intestinal Research
Verified
Journal Article
Open access
PDF file
KSKensuke Sakurai
Kensuke Sakurai
TKTakehiko Katsurada
Takehiko Katsurada
MNMutsumi Nishida
Mutsumi Nishida
SOSatomi Omotehara
Satomi Omotehara
SFShinya Fukushima
Shinya Fukushima
NSNaoya Sakamoto
Naoya Sakamoto
Background/Aims: The usefulness of ultrasonography (US) in diseases of the gastrointestinal tract has been reported recently. This prospective study aimed to determine the features of US findings in immune-mediated colitis (IMC), an adverse event induced by immune checkpoint inhibitor, and examine the correlation between US findings, colonoscopy (CS) findings, and severity of colitis.Methods: We studied patients examined using CS and US upon suspicion of IMC in Hokkaido University Hospital between April 2018 and February 2021. Endoscopic findings of IMC were assessed using the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). The severity of US findings in IMC was evaluated using US grade, which is the ultrasonographic grading scale in ulcerative colitis. Bowel wall thickness and the intensity of the color Doppler signal were also analyzed. Severity of colitis was evaluated using Common Terminology Criteria for Adverse Events (CTCAE) grade version 5.Results: Fourteen patients with IMC were enrolled. The US findings were bowel wall thickening, loss of stratification, ulceration and increased blood flow signal. The US grade was moderately correlated with the UCEIS (r=0.687, p=0.009) and CTCAE grade (r=0.628, p=0.035). Bowel wall thickness and UCEIS (r=0.628, p=0.020), as well as color Doppler signal grade and CTCAE grade (r=0.724, p=0.008), were significantly correlated.Conclusions: US findings in IMC were mainly similar to those of ulcerative colitis, but there were some findings that were characteristic only of IMC. Significant correlation was found between US findings, CS findings, and severity of colitis. Hence, US could be useful for the evaluation of IMC.

21 May 2009 in Journal of Echocardiography
Verified
Journal Article
Closed access
PDF file
SKSanae Kaga
Sanae Kaga
TMTaisei Mikami
Taisei Mikami
HOHisao Onozuka
Hisao Onozuka
SOSatomi Omotehara
Satomi Omotehara
AAAyumu Abe
Ayumu Abe
HTHiroyuki Tsutsui
Hiroyuki Tsutsui

31 January 2024 in Intestinal Research
Verified
Journal Article
Open access
PDF file
SFShinya Fukushima
Shinya Fukushima
TKTakehiko Katsurada
Takehiko Katsurada
MNMutsumi Nishida
Mutsumi Nishida
SOSatomi Omotehara
Satomi Omotehara
KSKensuke Sakurai
Kensuke Sakurai
NSNaoya Sakamoto
Naoya Sakamoto
Background/Aims: Transabdominal ultrasonography (US) helps evaluate Crohn’s disease (CD) activity. We investigated whether the US could predict subsequent adverse outcomes for patients with CD in clinical remission.Methods: This single-center retrospective study included patients with CD in clinical remission who underwent US between April 2011 and April 2021, focusing on the predictability of subsequent adverse outcomes within 5 years. We used the US-CD, which was calculated using multiple US findings. Predictive variables were assessed using Cox proportional hazards regression analysis, and the predictive value was evaluated using receiver operating characteristic curves.Results: Seventy-three patients were included. During a median follow-up of 1,441 days (range, 41–1,825 days), 16.4% (12/73) experienced clinical relapse, 9.6% (7/73) required endoscopic balloon dilation (EBD), 58.9% (43/73) required enhanced treatment, and 20.5% (15/73) underwent surgery. In the multivariate analysis, US-CD was significantly associated with clinical relapse (P= 0.038) and the need for enhanced treatment (P= 0.005). The area under the receiver operating characteristic curve for predicting clinical relapse and the need for EBD was 0.77 and 0.81, respectively, with US-CD (cutoff value = 11), and that for requiring enhanced treatment was 0.74 with US-CD (cutoff value = 6). Patients with US-CD ≥ 11 demonstrated a significantly higher occurrence of clinical relapse (P= 0.001) and EBD (P= 0.002) within 5 years. Patients with US-CD ≥ 6 experienced a significantly higher likelihood of requiring enhanced treatment (P< 0.001) within 5 years.Conclusions: High US-CD is associated with subsequent adverse outcomes in patients with CD.

1 February 2017 in Journal of Medical Ultrasonics
Verified
Journal Article
Closed access
PDF file
YKYusuke Kudo
Yusuke Kudo
TMTaisei Mikami
Taisei Mikami
MNMutsumi Nishida
Mutsumi Nishida
KOKazunori Okada
Kazunori Okada
SKSanae Kaga
Sanae Kaga
CSChikara Shimizu
Chikara Shimizu

1 April 2015 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
MSMegumi Satoh
Megumi Satoh
MNMutsumi Nishida
Mutsumi Nishida
YKYusuke Kudou
Yusuke Kudou
SOSatomi Omotehara
Satomi Omotehara
TITakahito Iwai
Takahito Iwai
HYHiroko Yamashita
Hiroko Yamashita